Rare case of Richter syndrome with testicular involvement successfully obtained good prognosis with rapid operation and immunochemotherapy.

CLL/SLL Richter syndrome diffuse large B‐cell lymphoma testicular germ cell tumor

Journal

IJU case reports
ISSN: 2577-171X
Titre abrégé: IJU Case Rep
Pays: Australia
ID NLM: 101764958

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 08 02 2019
accepted: 20 05 2019
entrez: 4 8 2020
pubmed: 17 6 2019
medline: 17 6 2019
Statut: epublish

Résumé

Richter syndrome refers to the transformation from chronic lymphocytic leukemia to assaultive lymphoma, often a diffuse large B-cell lymphoma, and has a greatly poor prognosis. Richter syndrome is characterized by rapidly growing lymphadenopathy but rarely presents with extra-nodal involvement, common sites being the digestive tract, lungs, kidneys, and central nervous system. However, Richter syndrome with testicular involvement is extremely rare. Herein we report a very scare case of a male at the age of 72 with Richter syndrome and testicular involvement, diagnosed by the investigation of bilateral scrotal swellings. The patient had attained disease-free survival for over a year with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, and the intrathecal administration of chemotherapeutic agents after diagnosis by immediate orchiectomy. An early pathological diagnosis by immediate orchiectomy and the early initiation of induction immunochemotherapy may be good prognostic factors in Richter syndrome involving the testes.

Identifiants

pubmed: 32743423
doi: 10.1002/iju5.12096
pii: IJU512096
pmc: PMC7292090
doi:

Types de publication

Case Reports

Langues

eng

Pagination

232-235

Informations de copyright

© 2019 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Indian J Pathol Microbiol. 2014 Jan-Mar;57(1):133-5
pubmed: 24739853
Am J Pathol. 1928 Jul;4(4):285-292.7
pubmed: 19969796
Br J Haematol. 2008 Jun;142(2):202-15
pubmed: 18492108
Best Pract Res Clin Haematol. 2016 Mar;29(1):30-39
pubmed: 27742070
Br J Haematol. 2013 Sep;162(6):774-82
pubmed: 23841899
Med Oncol. 2007;24(1):17-32
pubmed: 17673808
J Clin Oncol. 2006 May 20;24(15):2343-51
pubmed: 16710033

Auteurs

Kengo Kawase (K)

Department of Nephro-Urology Graduate School of Medical Sciences Nagoya City University Nagoya Aichi Japan.
Department of Urology Nagoya City East Medical Center Nagoya Aichi Japan.

Taku Naiki (T)

Department of Nephro-Urology Graduate School of Medical Sciences Nagoya City University Nagoya Aichi Japan.

Aya Naiki-Ito (A)

Pathology Division Nagoya City East Medical Center Nagoya Aichi Japan.

Masamitsu Yanada (M)

Department of Hematology and Cell Therapy Aichi Cancer Center Nagoya Aichi Japan.

Yosuke Ikegami (Y)

Department of Urology Nagoya City East Medical Center Nagoya Aichi Japan.

Yuya Ota (Y)

Department of Nephro-Urology Graduate School of Medical Sciences Nagoya City University Nagoya Aichi Japan.
Department of Urology Nagoya City East Medical Center Nagoya Aichi Japan.

Tatsuya Hattori (T)

Department of Urology Nagoya City East Medical Center Nagoya Aichi Japan.

Nayuka Matsuyama (N)

Department of Urology Nagoya City East Medical Center Nagoya Aichi Japan.

Takashi Hamakawa (T)

Department of Urology Nagoya City East Medical Center Nagoya Aichi Japan.

Tetsuji Maruyama (T)

Department of Urology Nagoya City East Medical Center Nagoya Aichi Japan.

Takahiro Yasui (T)

Department of Nephro-Urology Graduate School of Medical Sciences Nagoya City University Nagoya Aichi Japan.

Classifications MeSH